The clinical data of 374 HCC patients included age, sex, T stage, N stage, M stage, pathologic stage, histologic grade, race, weight, tumor status, OS event, DSS event, PFI event, age, AFP (ng/mL), and prothrombin time (Table 1). This evidence concerns the gene F2 and hepatocellular carcinoma.